Order Article Reprints

Sheikhi A, Baghaie L, Rahbarizadeh F, Safarzadeh Kozani P, Moradian C, Davidi M, Baharifar N, Kaboli G, Sheikhi M, Li Y, et al. Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity. Vaccines. 2025; 13(2):199. https://doi.org/10.3390/vaccines13020199

Sheikhi, Abdolkarim, Leili Baghaie, Fatemeh Rahbarizadeh, Pooria Safarzadeh Kozani, Cobra Moradian, Mohammadreza Davidi, Narges Baharifar, Golnaz Kaboli, Mehdi Sheikhi, Yunfan Li, and et al. 2025. "Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity" Vaccines 13, no. 2: 199. https://doi.org/10.3390/vaccines13020199

Sheikhi, A., Baghaie, L., Rahbarizadeh, F., Safarzadeh Kozani, P., Moradian, C., Davidi, M., Baharifar, N., Kaboli, G., Sheikhi, M., Li, Y., Meghdadi, M., Yaish, A. M., Yu, A. H., Harless, W. W., & Szewczuk, M. R. (2025). Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity. Vaccines, 13(2), 199. https://doi.org/10.3390/vaccines13020199